{
    "name": "florbetaben F 18",
    "comment": "Rx",
    "other_names": [
        "Neuraceq"
    ],
    "classes": [
        "Diagnostic Imaging Agents"
    ],
    "source": "https://reference.medscape.com/drug/neuraceq-florbetaben-f-18-999906",
    "pregnancy": {
        "common": [
            "There are no available data on pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Animal reproduction studies have not been conducted; all radiopharmaceuticals, have a potential to cause fetal harm depending on stage of fetal development and magnitude of radiopharmaceutical dose; if considering administration to a pregnant woman, inform patient about potential for adverse pregnancy outcomes based on radiation dose from drug and gestational timing of exposure"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug in human milk, effects on breastfed infant, or on milk production; exposure to a breastfed infant can be minimized by temporary discontinuation of breastfeeding",
            "Developmental and health benefits of breastfeeding should be considered along with mother's clinical need for drug and any potential adverse effects on breastfed child from drug from underlying maternal condition",
            "To decrease radiation exposure to breastfed infant, advise a lactating woman to pump and discard breast milk for 24 hours after administration of drug"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Risk for image misinterpretation",
                    "description": [
                        "Errors may occur in the estimation of brain neuritic plaque density during image interpretation; perform image interpretation independently of the patient’s clinical information",
                        "Other errors may be due to extensive brain atrophy that limits the ability to distinguish gray and white matter on the scan as well as motion artifacts that distort the image"
                    ]
                },
                {
                    "type": "Radiation risk",
                    "description": [
                        "Similar to other radiopharmaceuticals, flutemetamol F18 contributes to a patient’s overall long-term cumulative radiation exposure; long-term cumulative radiation exposure is associated with an increased risk of cancer",
                        "Ensure safe handling to protect patients and healthcare workers from unintentional radiation exposure"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Injection site pain",
            "percent": "3.9"
        },
        {
            "name": "Injection site erythema",
            "percent": "1.7"
        },
        {
            "name": "Injection site irritation",
            "percent": "1.2"
        }
    ]
}